Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 4 Results from the second estimation model of Iran from 1999 to 2017

From: Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries

Independent variables

Coefficient

t-Statistic

Probability

C

− 52.4201

− 4.9740

0.0006

GDP

− 0.0033

− 3.5449

0.0053

GHE

0.1694

8.5718

0.0000

DALY

0.0039

4.0904

0.0022

GENERICVOL

0.0102

3.6207

0.0047

PRICE

0.0007

4.1996

0.0018

INNOVATION

0.0002

1.0365

0.3244

PREVALENCE

0.0537

4.9530

0.0006

R-squared: 0.9967

Probability (F-statistic): 0.0001

D.W stat: 2.4733